3624 results for «2154»
3624 results
Minimally invasive aortic valve and ascending aortic replacement case from Leipzig Heart Center - Leipzig, Germany - Session with LIVE case
22 Nov 2020 – From PCR Valves e-Course 2020
A 62-year-old active male with severe stenosis of bicuspid aortic valve, ascending aortic aneurysm and obesity…
View this virtual LIVE case surgery recorded in Leipzig Heart Center, Germany – followed by LIVE call-ins from different city pods around the globe.
This session was originally presented during PCR Valves...
Tricuspid valve-in-valve case from London Bridge Hospital - London, United Kingdom - Session with LIVE case
24 Nov 2020 – From PCR Valves e-Course 2020
A 67-year-old male with degenerating 29mm Perimount tricuspid valve, right heart failure, and dyspnea on exertion (NYHA II), on optimal medical therapy…
View this virtual LIVE case transcatheter intervention recorded in London Bridge Hospital, London, United Kingdom – followed by LIVE call-ins from different city pods around...
PCR Valves e-Course 2020 Hotline - ACTIVATION trial, NIUT in patients with severe symptomatic calcific aortic stenosis, CUTTING-EDGE registry...
22 Nov 2020 – From PCR Valves e-Course 2020
- The percutAneous Coronary inTervention prIor to trans-catheter aortic VAlve implantaTION trial. S. Redwood: ACTIVATION Trial. S. Redwood
- Prospective, single-arm clinical investigation for the safety and feasibility study of Valvosoft NIUT in patients with severe symptomatic calcific aortic stenosis - First-in-man. E. Messas
- Outcomes of mitral valve surgery after...
PCR Valves e-Course 2020: Opening Ceremony
22 Nov 2020 – From PCR Valves e-Course 2020
Get a feel of the positive vibrations at #PCRvalves by watching a recording of the Opening ceremony, which was broadcast live from 3 TV studios in London, Paris and Toulouse! It shares how the comprehensive and innovative 3-day e-Course on the 3 valves – aortic, mitral...
20 years of TEER: a journey at the crossroads of the human heart
20 Nov 2023 – From PCR London Valves 2023
In 2023, with 200,000 MitraClips performed, the session concluded by posing the question of how many M-TEERs would be conducted by 2026. While the answer remains a mystery until PCR LV 2026, explore the fascinating history of transcatheter edge-to-edge mitral valve repair in this session. Delve...
PCR London Valves 2023 Closing Ceremony
21 Nov 2023 – From PCR London Valves 2023
Experience the highlights of PCR London Valve 2023 in this video retrospective, followed by insights from the Course Directors as they reflect on 3 dynamic and fruitful days that united 3,700 participants. Gratitude is extended to all contributors whose support was instrumental in the event's success....
Shared decision making in low-risk patients with aortic stenosis
16 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to discover how the concept of low-risk applies in Asian clinical practice, what is the impact of the TAVI low-risk trials on the management of individual patients, and learn more about the future role of the Heart Team.
Mitral valve disease: guidelines and beyond
21 Nov 2021 – From PCR London Valves 2021
In this session from PCR London Valves 2021 dedicated to the new guidelines relating to the management of mitral valve disease, discover how to apply them in your everyday clinical practice to the care of your patients through presentations, interviews, heart team discussions, a live case...
TAVI: all cases are not simple
16 Feb 2019 – From PCR Tokyo Valves 2019
Consult this session to learn more about how to deal with complex TAVI cases, with tips and tricks to face most of the difficult situations and to prevent potential complications.
Most interesting novel devices for the treatment of valvular heart disease
17 Feb 2019 – From PCR Tokyo Valves 2019
Consult this session to learn more about innovative perspectives for the interventional treatment of valvular heart disease, and discover some new devices which may truly impact your practice of transcatheter valve therapies in the future.
Major Late-Breaking Trials from EuroPCR 2025
21 May 2025 – From EuroPCR 2025
Discover major late-breaking trials from EuroPCR 2025 in this session presenting pivotal study data. Highlights include meta-analyses from the PROTECTED TAVR and BHF PROTECT-TAVI studies, angiography versus physiology-guided PCI during TAVI (FAITAVI trial), and novel antiplatelet strategies following drug-coated stent implantation in acute coronary syndrome, with...
TAVI for bioprosthetic valve failure - LIVE Case
22 May 2025 – From EuroPCR 2025
A 68-year-old male patient with a history of Sapien 3 26 mm TAVI (2021), complicated by the need for two valves (one displaced in the descending aorta) and permanent pacemaker implantation, as well as endocarditis (2022), presented with symptomatic bioprosthesis failure and reduced LV function (20...
The Future of TAVI
19 May 2022 – From EuroPCR 2022
Consut this session if you want to appraise the originality of the TAVI concept, to learn the feasibility of minimalist procedure and fast track patient pathway and to understand the expansion of indications and the future of TAVI.
TAVI in patients with long-life expectancy - LIVE case
16 May 2023 – From EuroPCR 2023
Watch the case of a 75-year-old male patient with history of TIA, symptomatic severe aortic stenosis with RBBB, and preserved LV function. The heart team's decision was to perform TAVI with PCI on LAD a few days before procedure.
First, a cerebral protection device (Sentinel) was implanted....
TAVI for patients with concomitant coronary artery disease - LIVE case
17 Feb 2024 – From PCR Tokyo Valves 2024
An 88-year-old male presented a severe symptomatic aortic valve with preserved LV function (64%), a coronary artery disease with a LAD PCI a few years ago and a significant (75%) RCA stenosis with an FFR angio at 0.74. He also has a short membrane septum (2.5...
The optimal first valve choice for patients with aortic stenosis - Key considerations for lifetime management
17 Feb 2024 – From PCR Tokyo Valves 2024
This session tackles the pressing topic of TAVI's success in treating aortic stenosis, particularly in younger patients, and the ensuing questions regarding device durability, potential follow-up procedures, and the interplay between TAVI and surgical options. The aim is to ensure optimal decision-making that prioritizes patient welfare...
TAVI in TAVI - LIVE case
14 May 2024 – From EuroPCR 2024
A 74-year-old male with a history of cancer, TAVI with Evolut R 34 in 2019, COPD, obesity, and RBBB presents with a symptomatic degenerated valve (regurgitation).
It was decided to implant a Sapien 3 Ultra 26, without pre-dilatation and post-dilatation, using a temporary pacing lead (due to...
These EuroIntervention papers changed my practice!
15 May 2024 – From EuroPCR 2024
Pre-emptive TAVI for asymptomatic severe aortic stenosis - From headlines to clinical practice
24 Nov 2024 – From PCR London Valves 2024
Is early TAVI the right choice for your asymptomatic patients with severe aortic stenosis? In this video, we break down the latest clinical trials, including EARLY TAVR and EVOLVED, to help you navigate the complex decision-making process.
Find out what these studies really tell us about the...
New iterations of self expendable valves - LIVE case
25 Nov 2024 – From PCR London Valves 2024
Watch a LIVE case followed by a recorded case on enhanced TAVI:
- An 80-year-old female with severe symptomatic aortic stenosis, a complete right bundle branch block (RBB), and preserved LV function. The operators implanted a 25 mm ACURATE Prime valve following predilation with a 22 mm balloon....
